撤回：碘普罗胺与碘克沙醇在肾功能不全患者术后造影剂肾病发生中的作用：一项荟萃分析。
Retracted: Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.
作者信息
Healthcare Engineering Journal Of
出版信息
J Healthc Eng. 2023 Jan 19;2023:9864315. doi: 10.1155/2023/9864315. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/1469370.].
摘要
[本文撤回文章DOI: 10.1155/2022/1469370。]
相似文献
1
Retracted: Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.撤回：碘普罗胺与碘克沙醇在肾功能不全患者术后造影剂肾病发生中的作用：一项荟萃分析。
J Healthc Eng. 2023 Jan 19;2023:9864315. doi: 10.1155/2023/9864315. eCollection 2023.
2
Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.碘普罗胺和碘克沙醇在肾功能不全患者术后对比肾病中的作用：一项荟萃分析。
J Healthc Eng. 2022 Apr 5;2022:1469370. doi: 10.1155/2022/1469370. eCollection 2022.
3
Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.碘克沙醇与碘普罗胺用于接受或未接受经皮冠状动脉介入治疗的肾功能不全患者的冠状动脉造影术对比研究
Medicine (Baltimore). 2018 May;97(18):e0617. doi: 10.1097/MD.0000000000010617.
4
Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.碘海醇和碘普罗胺在肾功能不全患者冠状动脉造影中对比性肾毒性的比较。
Am J Cardiol. 2011 Jul 15;108(2):189-94. doi: 10.1016/j.amjcard.2011.03.019. Epub 2011 May 3.
5
The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.非离子型、含碘对比剂的渗透压作为肾安全性的一个重要因素。
Invest Radiol. 2012 Sep;47(9):503-10. doi: 10.1097/RLI.0b013e318258502b.
6
Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.与碘普罗胺相比，碘克沙醇在肾功能磁共振成像参数及造影剂滞留方面的显著扰动：一项在大鼠中使用血氧水平依赖/扩散加权磁共振成像和计算机断层扫描的实验研究
Invest Radiol. 2014 Nov;49(11):699-706. doi: 10.1097/RLI.0000000000000073.
7
Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.562 例肾功能损害患者行心导管检查术的碘普罗胺和碘克沙醇的肾脏耐受性：DIRECT 研究。
EuroIntervention. 2012 Nov 22;8(7):830-8. doi: 10.4244/EIJV8I7A126.
8
Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.碘克沙醇和碘普罗胺对肾功能异常患者在冠状动脉造影和介入治疗前接受N-乙酰半胱氨酸和水化治疗时的肾毒性作用：一项随机试验。
Intern Med J. 2009 Jan;39(1):25-31. doi: 10.1111/j.1445-5994.2008.01675.x. Epub 2008 Sep 2.
9
Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat.在大鼠中，等渗性造影剂可使尿液黏度增加高达 50 倍。
Radiology. 2010 Aug;256(2):406-14. doi: 10.1148/radiol.10091485. Epub 2010 Jun 7.
10
Comparison of Iodixanol and Iopromide in Patients With Renal Insufficiency and Congestive Heart Failure Undergoing Coronary Angiography by Hemodynamic Monitoring.对比碘克沙醇和碘普罗胺在接受冠状动脉造影术的伴有肾功能不全和充血性心力衰竭患者中的应用，通过血流动力学监测。
Angiology. 2017 Nov;68(10):907-913. doi: 10.1177/0003319717701868. Epub 2017 Apr 12.
本文引用的文献
1
Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis.碘普罗胺和碘克沙醇在肾功能不全患者术后对比肾病中的作用：一项荟萃分析。
J Healthc Eng. 2022 Apr 5;2022:1469370. doi: 10.1155/2022/1469370. eCollection 2022.
Zotero 插件